Sept. 2, 2011 — -- In a case that mixes reproductive technology, family law and employment law, a woman who used a surrogate to give birth to her twins is suing her employer and a senior human resources analyst in a U.S. District Court in Massachusetts for refusing to grant her paid maternity leave.
Kara Krill, a clinical business manager on New York's Long Island, has claimed breach of contract, breach of good faith and fair dealing, discrimination on the basis of her disability and gender, and negligent misrepresentation on the part of Cubist Pharmaceuticals, headquartered in Lexington, Mass. She seeks an injunction and compensatory and punitive damages for employment law violations.
Krill, who developed a reproductive disability called Asherman's syndrome after she gave birth to her first child in June 2007, and her husband hired a surrogate mother, or gestational carrier, to carry and deliver their second child. After learning the gestational carrier was pregnant with twins in November 2010, Krill informed her employer that she expected to go on paid maternity leave when the twins were born in May 2011, according to the suit.
Krill and her husband also obtained a prebirth order that "established the legal and genetic parentage of Krill's twins without having to institute adoption proceedings," according to court documents.
When Krill had her first child in June 2007, she received 13 weeks of paid leave under Cubist's maternity leave policy.
But a Cubist human resources analyst informed Krill she would be entitled to five days of paid leave under Cubist's adoption leave policy and not any paid leave under Cubist's maternity leave policy. The company provides adopting parents who work 20 hours or more per week five paid days of leave plus up to $4,000 in expenses for the adoption, according to court documents. The company's paternity leave policy also provides male employees who work 20 hours or more per week five paid days of leave.
In an email to the human resources employee, Krill complained about what she said was discriminatory treatment.
"As we have previously informed you, the children being born are mine and were conceived with my husband. They are only being carried by [a gestational carrier] as a result of my physical disability. ... Cubist's treatment of me differently than other employees having babies is not fair and is placing me in an untenable condition," she wrote, according to court documents. "But for my physical disability, I would be receiving the paid maternity leave offered by Cubist. Accommodating my disability would not require [Cubist] to provide me with any more benefit than other mothers."
The suit also claims that Krill's direct supervisor subjected Krill to "verbal harassment and other adverse treatment," "frequently" patronizing Krill about her disability. Her supervisor "told her pointedly on several different occasions that she should not be entitled to any leave from Cubist for the birth of her children, whether paid or unpaid," according to court documents.
When Krill informed her supervisor she was required to be with her newborn children for a minimum of 12 weeks, her supervisor told Krill that she could "'put [her] twins in daycare,' so she could come back to work sooner.'" Her supervisor also informed Krill she was "changing her sales quota expectations and taking away one of Krill's largest customer accounts and assigning it to another Cubist employee who was not disabled, and not going out on maternity leave."
Francis McLoughlin, director of corporate communications at Cubist, said the company could not comment on ongoing litigation but that Cubist "tries to maintain positive work relations at the company."
The Boston Globe has included Cubist in its annual list of Top Places to Work in Massachusetts for the past three years. The pharmaceutical company ranked 24th among midsize companies and was the highest-ranking public life-sciences company in its category in November 2010.
Charles F. Rodman, Krill's attorney, said she was "anxious" for the federal court to determine her claims.